| Cholesterol embolization syndrome. Occurrence after intravenous streptokinase therapy for myocardial infarction. | |
| | |
MedLine Citation:
|
PMID: 3656605 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Two patients developed the cholesterol embolization syndrome after coronary angiography and intravenous streptokinase therapy for acute myocardial infarction. Clinical manifestations included cyanosis, ulcers, gangrene of the hands and feet, myalgias, intestinal infarction, eosinophilia, and renal failure. One patient died; one has survived with chronic renal failure. Streptokinase therapy may expose atheromatous plaques to the circulation by lysing platelet-fibrin thrombi. |
| | |
Authors:
|
M W Schwartz; G B McDonald |
Related Documents
:
|
3315575 - Early clinical evaluation of the intravenous treatment of acute myocardial infarction w... 3315585 - Acute coronary occlusion and reperfusion. reliability of angiographic classification an... 14728075 - Does magnesium have a role in the treatment of patients with coronary artery disease? 22104165 - Improved left ventricular mass quantification with partial voxel interpolation: in vivo... 7955235 - Arrhythmias and sudden death after dynamic cardiomyoplasty. 7736485 - Circadian variation and triggers of cardiovascular disease. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: JAMA : the journal of the American Medical Association Volume: 258 ISSN: 0098-7484 ISO Abbreviation: JAMA Publication Date: 1987 Oct |
Date Detail:
|
Created Date: 1987-10-29 Completed Date: 1987-10-29 Revised Date: 2006-11-07 |
Medline Journal Info:
|
Nlm Unique ID: 7501160 Medline TA: JAMA Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 1934-5 Citation Subset: AIM; IM |
Affiliation:
|
Department of Medicine, Veterans Administration Medical Center, Seattle, WA 98108. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cholesterol* Coronary Angiography* Embolism, Fat / etiology* Female Humans Male Middle Aged Myocardial Infarction / drug therapy Streptokinase / adverse effects*, therapeutic use |
| Chemical | |
Reg. No./Substance:
|
57-88-5/Cholesterol; EC 3.4.-/Streptokinase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Dipstick leukocyte esterase activity in first-catch urine specimens. A useful screening test for det...
Next Document: Pregnancy and birth rates among sexually experienced US teenagers--1974, 1980, and 1983.